AQUINOX PHARMACEUTICALS, INC (35) | Human Resources (12)
Browse by Subcategory
Recent Contracts
-
Employment Agreement, dated April 14, 2021, by and between Neoleukin Therapeutics, Inc. and Priti Patel
(Filed With SEC on March 1, 2022)
-
Neoleukin Therapeutics, Inc. Amended and Restated 2014 Equity Incentive Plan
(Filed With SEC on May 14, 2021)
-
Separation Agreement and Release, dated August 5, 2019, by and between Aquinox Pharmaceuticals, Inc., and David J. Main
(Filed With SEC on August 6, 2019)
-
Transition Retention Agreement, dated August 5, 2019, by and between Aquinox Pharmaceuticals, Inc., and Kamram Alam
(Filed With SEC on August 6, 2019)
-
Executive Employment Agreement, dated September 29, 2020, by and between Neoleukin Therapeutics, Inc., and Holly Vance
(Filed With SEC on March 25, 2021)
-
Forms of Restricted Stock Unit Agreement and Restricted Stock Unit Grant Notice for Registrants 2014 Equity Incentive Plan
(Filed With SEC on August 12, 2020)
-
Employment Agreement, dated March 16, 2020, by and between Neoleukin Therapeutics, Inc. and Robert Ho
(Filed With SEC on May 6, 2020)
-
Amended and Restated Executive Employment Agreement, dated April 15, 2020, by and between Neoleukin Therapeutics, Inc., and Jonathan G. Drachman
(Filed With SEC on April 17, 2020)
-
Neoleukin Therapeutics, Inc. 2014 Equity Incentive Plan, as amended November 12, 2019
(Filed With SEC on November 14, 2019)
-
Employment Agreement, dated August 5, 2019, by and between Aquinox Pharmaceuticals, Inc., and Jonathan G. Drachman
(Filed With SEC on August 6, 2019)
-
Executive Employment Agreement Amendment for David Main
(Filed With SEC on August 1, 2019)
-
Executive Employment Agreement Amendment for Kamran Alam
(Filed With SEC on August 1, 2019)